Risk factors and neurodegenerative mechanisms in stroke related dementia

Panminerva Medica

Volumn 54, Issue 3, 2012, Pages 139-148

  Kalaria, R N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Ageing; Alzheimer disease; Cognitive impairment; Dementia; Stroke

Indexed keywords

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN MAPPING; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CEREBRAL INFARCTION; COGNITION; COGNITION DISORDERS; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; RISK FACTORS; STROKE;

EID: 84867169353     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neu-rol 2008;7:812-26.
2. Leys D, Henon H, Mackowiak-Cordoliani M A, Pasquier F. Post-stroke dementia. Lancet Neurol 2005;4:752-9.
3. Borenstein AR, Copenhaver CI, Mortimer JA. Early-life risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 2006;20:63-72. (Pubitemid 44356897)
4. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545-51. (Pubitemid 41170713)
5. Morris CM, Ballard CG, Allan L, Rowan E, Stephens S, Firbank M et al. NOS3 gene rs 1799983 polymorphism and incident dementia in elderly stroke survivors. Neurobiol Aging 2011;32:554.el-6.
6. Jones EL, Kalaria RN, Sharp SI, O'Brien JT, Francis PT, Ballard CG. Genetic associations of autopsy-confirmed vascular dementia subtypes. Dement Geriatr Cogn Disord 2011;31:247-53.
7. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's dis-ease. Am J Pathol 1996;148:2083-95.
8. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487-99. (Pubitemid 40982459)
9. Markus HS. Stroke genetics. Hum Mol Genet 2011;20:R124-31.
10. Fornage M, Debette S, Bis JC, Schmidt H, Ikram M A, Dufouil C et al. Genome-wide association studies of cerebral white matter le-sion burden: the CHARGE consortium. Ann Neurol 2011;69:928-39.
11. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol 2009;8:355-69.
12. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: A population-based study. Lancet Neurol 2007;6:487-93.
13. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. De-mentia after ischemic stroke: a population-based study in Roches-ter, Minnesota (1960-1984). Neurology 1996;46:154-9. (Pubitemid 26156122)
14. Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Pol-vikoski TM et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain 2012;134:3716-27.
15. Savva GM, Stephan BC. Epidemiological studies of the ef-fect of stroke on incident dementia: A systematic review. Stroke 2010;41:e41-6.
16. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol 2009;8:1006-18.
17. Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospec-tive follow-up study between 3 and 15 months after stroke: im-provements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke 2003;34:2440-44. (Pubitemid 37221958)
18. Narasimhalu K, Ang S, De Silva DA, Wong MC, Chang HM, Chia KS et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology 2009;73:1866-72.
19. Melkas S, Oksala NK, Jokinen H, Pohjasvaara T, Vataja R, Oksala A et al. Poststroke dementia predicts poor survival in long-term follow-up: Influence of prestroke cognitive decline and previous stroke. J Neurol Neurosurg Psychiatry 2009;80:865-70.
20. Bejot Y, Aboa-Eboule C, Durier J, Rouaud O, Jacquin A, Ponavoy E et al. Prevalence of early dementia after first-ever stroke: A 24-year population-based study. Stroke 2011;42:607-12.
21. Altieri M, Di Piero V, Pasquini M, Gasparini M, Vanacore N, Vi-cenzini E et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004;62:2193-7. (Pubitemid 38787774)
22. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;37:345-50. (Pubitemid 43731985)
23. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke 1998;29:75-81. (Pubitemid 28046945)
24. Inzitari D, Di Carlo A, Pracucci G, Lamassa M, Vanni P, Romanelli M et al. Incidence and determinants of poststroke dementia as de-fined by an informant interview method in a hospital-based stroke registry. Stroke 1998;29:2087-93. (Pubitemid 28443523)
25. Censoři B, Manara O, Agostinis C, Camerlingo M, Casto L, Gala-votti B et al. Dementia after first stroke. Stroke 1996;27:1205-10. (Pubitemid 26226956)
26. Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke 2000;31:1494-501. (Pubitemid 30437493)
27. Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 2008;39:36-41.
28. Mackowiak-Cordoliani MA, Bombois S, Memin A, Henon H, Pasquier F. Poststroke dementia in the elderly. Drugs Aging 2005;22:483-93. (Pubitemid 41003062)
29. Sachdev PS, Chen X, Brodaty H, Thompson C, Altendorf A, Wen W. The determinants and longitudinal course of post-stroke mild cognitive impairment. J Int Neuropsychol Soc 2009;15:915-23.
30. Srikanth VK, Quinn SJ, Donnan GA, Saling MM, Thrift AG. Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 2006;37:2479-83. (Pubitemid 44454664)
31. Ingles JL, Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 2002;33:1999-2002. (Pubitemid 34840057)
32. Oksala NK, Jokinen H, Melkas S, Oksala A, Pohjasvaara T, Hi-etanen M et al. Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry 2009;80:1230-5.
33. Barba R, Morin MD, Cemillan C, Delgado C, Domingo J, Del Ser T. Previous and incident dementia as risk factors for mortality in stroke patients. Stroke 2002;33:1993-8. (Pubitemid 34840056)
34. del Ser T, Barba R, Morin MM, Domingo J, Cemillan C, Pondal M et al. Evolution of cognitive impairment after stroke and risk fac-tors for delayed progression. Stroke 2005;36:2670-5.
35. Tham W, Auchus AP, Thong M, Goh ML, Chang HM, Wong MC et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sei 2002;203-204:49-52. (Pubitemid 35287374)
36. Henon H, Pasquier F, Durieu I, Pravo JP, Leys D. Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry 1998;65:641-7. (Pubitemid 28486638)
37. Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C et al. Medial temporal atrophy rather than white matter hyper-intensities predict cognitive decline in stroke survivors. Neurobiol Aging 2007;28:1664-9. (Pubitemid 47384946)
38. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in alzheimer disease. Nat Rev Neu-rol 2010;6:67-77.
39. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999;52:1153-40.
40. Bastos-Leite AJ, van der Flier WM, van Straaten ECW, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007;38:3182-5.
41. Scher AI, Xu Y, Korf ESC, Hartley SW, Witter MP, Scheltens P et al. Hippocampal morphometry in population-based incident alzheimer's disease and vascular dementia: The HAAS. J Neurol Neurosurg Psychiatry 2011;82:373-6.
42. Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippoc-ampal neuronal loss. J Neurol Neurosurg Psychiatry 2002;72:747-51. (Pubitemid 34557018)
43. Barber R, Ballard C, McKeith IG, Gholkar A, O'Brien JT. MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology 2000;54:1304-9. (Pubitemid 30174051)
44. O'Sullivan M, Ngo E, Viswanathan A, Jouvent E, Gschwendtner A, Saemann PG et al. Hippocampal volume is an independent predic-tor of cognitive performance in CADASIL. Neurobiology of Aging 2009;30:890-7.
45. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neu-ron number in the entorhinal cortex and CAl in preclinical Alzhe-imer disease. Arch Neurol 2001;58:1395-402. (Pubitemid 32845990)
46. Kril JJ, Hodges J, Halliday G. Relationship between hippocampal volume and CAl neuron loss in brains of humans with and without Alzheimer's disease. Neuroscience Letters 2004;361:9-12. (Pubitemid 38609203)
47. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hip-pocampus in brain ischemia. Neuroscience 1991;40:599-636.
48. Wu W, Brickman AM, Luchsinger J, Ferrazano P, Pichiule P, Yoshi-ta M et al. The brain in the age of old: The hippocampal formation is targeted differentially by diseases of late-life. Annals of Neurol-ogy 2008;64:698-706.
49. West MJ, Coleman PD, Flood DG, Trancoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzhe-imer's disease. Lancet 1994;344:769-72. (Pubitemid 24283954)
50. Apostolova LG, Green AE, Babakchanian S, Hwang S, Chou Y-Y, Toga AW et al. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26:17-27.
51. Pakkenberg B, Pelvig D, Marner L, Bundgaard MJ, Gundersen HJG, Nyengaard JR et al. Aging and the human neocortex. Experi-mental Gerontology 2003;38:95-9. (Pubitemid 36110503)
52. Rössler M, Zarski R, Bohl J, Ohm T. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathologica 2002;103:363-9. (Pubitemid 36097031)
53. Korbo L, Amrein I, Lipp HP, Wolfer D, Regeur L, Oster S et al. No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients. Acta Neurológica Scandinavica 2004;109:132-9. (Pubitemid 38175053)
54. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 2005;57:896-903.
55. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in nor-mal human adult aging. Ann Neurol 1987;21:530-9. (Pubitemid 17081187)
56. Swaab DF, Hofman MA, Lucassen PJ, Salehi A, Uylings HBM. Neuronal atrophy, not cell death, is the main hallmark of Alzhe-imer's disease. Neurobiol Aging 1994;15:369-71. (Pubitemid 24194883)
57. Freeman S, Kandel R, Crus L, Rozkalne A, Newell K, Frosch MP et al. Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease. J Neu-ropathol Exp Neurol 2008;67:1205-12.
58. Morrison JH, Hof PR, Efrain C. Chapter 37. Selective vulnerabil-ity of corticocortical and hippocampal circuits in aging and Alzhe-imer's disease. Progress in Brain Research Amsterdam: Elsevier; 2002 467-86.
59. Fjell AM, Walhovd KB. Structural brain changes in aging: Courses, causes and cognitive consequences. Reviews in the Neurosciences 2010;21:187-222.
60. Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar A, Oak-ley AE et al. Hippocampal neuronal atrophy and cognitive func-tion in delayed poststroke and aging-related dementias. Stroke 2012;43:808-14.
61. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN et al. Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 2011;76:1478-84.
62. Bowler JV, Munoz DG, Merskey H, Hachinski V. Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;64:18-24. (Pubitemid 28156532)
63. Kalaria R. Similarities between Alzheimer's disease and vascular dementia. J Neurol Sei 2002;203-204:29-34. (Pubitemid 35287372)
64. Mok V, Leung EY, Chu W, Chen S, Wong A, Xiong Y et al. Pitts-burgh compound B binding in poststroke dementia. J Neurol Sci 2010;290:135-7.
65. Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM et al. Quantification of Alzheimer pathology in ageing and dementia: Age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol 2006;32:103-18.
66. Hsiung GY, Donald A, Grand J, Black SE, Bouchard RW, Gauth-ier SG et al. Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dement Geriatr Cogn Disord 2006;22:413-20. (Pubitemid 44726011)
67. Kalaria RN, Ballard C. Stroke and cognition. Curr Atheroscler Rep 2001;3:334-9.
68. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions in-crease stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9. (Pubitemid 36547501)
69. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-9. (Pubitemid 46921055)
70. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-22. (Pubitemid 36359297)
71. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koud-staal PJ et al. Cerebral small-vessel disease and decline in infor-mation processing speed, executive function and memory. Brain 2005;128:2034-41. (Pubitemid 41253271)
72. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 2000;21:321-30. (Pubitemid 30387091)
73. Suter OC, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K et al. Cerebral hypoperfusion generates cortical watershed micro-infarcts in Alzheimer disease. Stroke 2002;33:1986-92. (Pubitemid 34840055)
74. Gold G, Kovari E, Hof PR, Bouras C, Giannakopoulos P. Sorting out the clinical consequences of ischemic lesions in brain aging: a clinicopathological approach. J Neurol Sci 2007;257:17-22. (Pubitemid 46856493)
75. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC et al. Cerebral infarcts in patients with autopsy-prov-en Alzheimer's disease: CERAD, part XVIII. Consortium to Estab-lish a Registry for Alzheimer's Disease. Neurology 1998;51:159-62. (Pubitemid 28345377)
76. Kalaria RN, Ballard C. Overlap between pathology of Alzheim-er disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13(Suppl3):S115-23
77. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-7. (Pubitemid 27111317)
78. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loe-wenstein D et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002;16:203-12. (Pubitemid 35434796)
79. Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med 2004;128:32-8. (Pubitemid 38049563)
80. Nolan KA, Lino MM, Seligmann AW, Blass JP. Absence of vas-cular dementia in an autopsy series from a dementia clinic. J Am Geriatr Soc 1998;46:597-604. (Pubitemid 28237118)
81. Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, Salviati A et al. Vascular dementia in a population-based autopsy study. Arch Neurol. 2003;60:569-75. (Pubitemid 36427971)
82. Ballard C, McKeith I, O'Brien J, Kalaria R, Jaros E, Ince P et al. Neuropathological substrates of dementia and depression in vas-cular dementia, with a particular focus on cases with small infarct volumes. Dement Geriatr Cogn Disord 2000;11:59-65. (Pubitemid 30114085)
83. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neuro-surg Psychiatry 1997;63:749-53. (Pubitemid 27520751)
84. Pasquier F, Leys D, Scheltens P. The influence of coincidental vas-cular pathology on symptomatology and course of Alzheimer's dis-ease. J Neural Transm Suppl 1998,54:117-27. (Pubitemid 28539348)
85. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004;226:75-80. (Pubitemid 39505411)
86. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931-45.
87. MRC-CFAS. Neuropathology group of the medical research council cognitive function and ageing study, pathological cor-relates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75.
88. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 2002;977:9-23. (Pubitemid 35418132)
89. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cer-ebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 2004;62:1148-55. (Pubitemid 38456510)
90. Launer LJ, Petrovitch H, Ross GW, Markesbery W, White LR. AD brain pathology: Vascular origins? Results from the HAAS autopsy study. Neurobiol Aging 2008;29:1587-90.
91. Fratiglioni L, Wang HX. Brain reserve hypothesis in dementia. J Alzheimers Dis 2007;12:11-22. (Pubitemid 47396305)
92. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612-23. (Pubitemid 351626845)
93. Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Pathology of lacu-nar ischaemic stroke in humans - A systematic review. Brain Pathol 2012;doi: 10.1111/j. 1750-3639.2012.00575.x
94. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C et al. Incidence, manifestations, and pre-dictors of worsening white matter on serial cranial magnetic res-onance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005;36:56-61. (Pubitemid 40054175)
95. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Har-skamp F et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4. (Pubitemid 27039193)
96. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R et al. Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neu-ropathol 2007;113:13-21. (Pubitemid 44782925)
97. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nils-son L et al. 15-year longitudinal study of blood pressure and de-mentia. Lancet 1996;347:1141-5. (Pubitemid 126512042)
98. Sparks DL, Hunsaker JC 3rd, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990; 11:601-7.
99. Purnell C, Gao S, Callahan CM, Hendrie HC. Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature. Alzheimer Dis Assoc Disord 2009;23:1-10.
100. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996;39:1392-7. (Pubitemid 26356072)
101. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997;145:301-8. (Pubitemid 27082028)
102. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch Neurol 2009;66:300-5.
103. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vas-cular dementia. Curr Alzheimer Res 2007;4:103-9. (Pubitemid 46557496)